{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:14:24Z","timestamp":1790889264072,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007638","name":"Kidney Foundation, Japan","doi-asserted-by":"publisher","award":["JKFB11-30"],"award-info":[{"award-number":["JKFB11-30"]}],"id":[{"id":"10.13039\/501100007638","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00223-017-0347-3","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T11:49:11Z","timestamp":1508500151000},"page":"310-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effects of Lanthanum Carbonate on Coronary Artery Calcification and Cardiac Abnormalities After Initiating Hemodialysis"],"prefix":"10.1007","volume":"102","author":[{"given":"Hideki","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"issue":"5","key":"347_CR1","first-page":"15","volume":"2015","author":"N Hanafusa","year":"2011","unstructured":"Hanafusa N, Nakai S, Iseki K, Tsubakihara Y (2011) Japanese society for dialysis therapy renal data registry\u2014a window through which we can view the details of Japanese dialysis population. Kidney Int Suppl 2015(5):15\u201322","journal-title":"Kidney Int Suppl"},{"key":"347_CR2","unstructured":"U.S. Renal Data System, USRDS 2014 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases"},{"issue":"12","key":"347_CR3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ki.2010.70","volume":"77","author":"YW Chiu","year":"2010","unstructured":"Chiu YW, Adler SG, Budoff MJ, Takasu J, Ashai J, Mehrotra R (2010) Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int 77(12):1107\u20131114","journal-title":"Kidney Int"},{"key":"347_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S4822","volume":"5","author":"RJ Rennenberg","year":"2009","unstructured":"Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA (2009) Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 5:185\u2013197","journal-title":"Vasc Health Risk Manag"},{"key":"347_CR5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM, Gu\u00e9rin AP, Marchais SJ, M\u00e9tivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl 18:1731\u20131740","journal-title":"Nephrol Dial Transpl"},{"key":"347_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","volume":"116","author":"E Schiffrin","year":"2007","unstructured":"Schiffrin E, Lipman ML, Mann JF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116:85\u201397","journal-title":"Circulation"},{"issue":"6","key":"347_CR7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","volume":"95","author":"SM Moe","year":"2004","unstructured":"Moe SM, Chen NX (2004) Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 95(6):560\u2013567","journal-title":"Circ Res"},{"issue":"Suppl 5","key":"347_CR8","doi-asserted-by":"crossref","first-page":"V59","DOI":"10.1093\/ndt\/gfh1058","volume":"19","author":"J Floege","year":"2004","unstructured":"Floege J, Ketteler M (2004) Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transpl 19(Suppl 5):V59\u201366","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"347_CR9","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono S, McKee MD, Murry CE et al (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87(7):E10\u201317","journal-title":"Circ Res"},{"issue":"2","key":"347_CR10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2008040349","volume":"20","author":"KL Adeney","year":"2009","unstructured":"Adeney KL, Siscovick DS, Ix JH et al (2009) Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20(2):381\u2013387","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"347_CR11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ki.2015.117","volume":"88","author":"KU Eckardt","year":"2015","unstructured":"Eckardt KU, Gillespie IA, Kronenberg F et al (2015) ARO steering committee. High cardiovascular event rates occur within the first weeks of starting hemodialysis. Kidney Int 88(5):1117\u20131125","journal-title":"Kidney Int"},{"key":"347_CR12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.2013.252","volume":"85","author":"BM Robinson","year":"2014","unstructured":"Robinson BM, Zhang J, Morgenstern H et al (2014) Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int 85:158\u2013165","journal-title":"Kidney Int"},{"issue":"3","key":"347_CR13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa M, Yokoyama K, Koiwa F et al (2013) CKD-MBD guideline working group; Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17(3):247\u2013288","journal-title":"Ther Apher Dial"},{"key":"347_CR14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827\u2013832","journal-title":"J Am Coll Cardiol"},{"key":"347_CR15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450\u2013458","journal-title":"Am J Cardiol"},{"key":"347_CR16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1797.2010.01412.x","volume":"16","author":"ND Toussaint","year":"2011","unstructured":"Toussaint ND, Lau KK, Polkinghorne KR, Kerr PG (2011) Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: a pilot randomized controlled trial. Nephrology 16:290\u2013298","journal-title":"Nephrology"},{"key":"347_CR17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","volume":"167","author":"R Dhingra","year":"2007","unstructured":"Dhingra R, Sullivan LM, Fox CS et al (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879\u2013885","journal-title":"Arch Intern Med"},{"key":"347_CR18","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Cholesterol and recurrent events trial investigators. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627\u20132633","journal-title":"Circulation"},{"key":"347_CR19","doi-asserted-by":"crossref","unstructured":"Schoenhagen P, Tuzcu EM (2002) Coronary artery calcification and end-stage renal disease: vascular biology and clinical implications. Cleve Clin J Med 69(Supple 3):S12\u2013S20","DOI":"10.3949\/ccjm.69.Suppl_3.S12"},{"issue":"3","key":"347_CR20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ki.2012.118","volume":"82","author":"K Kono","year":"2012","unstructured":"Kono K, Fujii H, Nakai K et al (2012) Compositional plaque pattern of coronary culprit lesion and clinical characteristics in chronic kidney disease patients: a virtual histology-intravascular ultrasound (VH-IVUS) analysis. Kidney Int 82(3):344\u2013351","journal-title":"Kidney Int"},{"issue":"6","key":"347_CR21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ajh.2008.29","volume":"21","author":"H Fujii","year":"2008","unstructured":"Fujii H, Takiuchi S, Kawano Y, Fukagawa M (2008) Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients. Am J Hypertens 21(6):650\u2013656","journal-title":"Am J Hypertens"},{"key":"347_CR22","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/ndt\/gfq113","volume":"25","author":"Y Caliskan","year":"2010","unstructured":"Caliskan Y, Demirturk M, Ozkok A et al (2010) Coronary artery calcification and coronary flow velocity in haemodialysis patients. Nephrol Dial Transpl 25:2685\u20132690","journal-title":"Nephrol Dial Transpl"},{"key":"347_CR23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jacc.2007.06.027","volume":"50","author":"L Cortigiani","year":"2007","unstructured":"Cortigiani L, Rigo F, Gherardi S et al (2007) Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 50:1354\u20131361","journal-title":"J Am Coll Cardiol"},{"key":"347_CR24","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1681\/ASN.2015030301","volume":"27","author":"NR Shar","year":"2016","unstructured":"Shar NR, Charytan DM, Murthy VL et al (2016) Prognostic value of coronary flow reserve in patients with dialysis-dependent ESRD. J Am Soc Nephrol 27:1823\u20131829","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"347_CR25","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","volume":"15","author":"AP Gu\u00e9rin","year":"2000","unstructured":"Gu\u00e9rin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transpl 15(7):1014\u20131021","journal-title":"Nephrol Dial Transpl"},{"key":"347_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P (2002) Treat to goal working group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245\u2013252","journal-title":"Kidney Int"},{"issue":"4","key":"347_CR27","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","volume":"68","author":"GA Block","year":"2005","unstructured":"Block GA, Spiegel DM, Ehrlich J et al (2005) Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68(4):1815\u20131824","journal-title":"Kidney Int"},{"issue":"3","key":"347_CR28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2010.10.055","volume":"57","author":"T Kakuta","year":"2011","unstructured":"Kakuta T, Tanaka R, Hyodo T et al (2011) Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients. Am J Kidney Dis 57(3):422\u2013431","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"347_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CN106830","volume":"78","author":"RS Kalil","year":"2012","unstructured":"Kalil RS, Flanigan M, Stanford W, Haynes WG (2012) Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study. Clin Nephrol 78(1):1\u20139","journal-title":"Clin Nephrol"},{"issue":"4","key":"347_CR30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/1744-9987.12153","volume":"18","author":"K Wada","year":"2014","unstructured":"Wada K, Wada Y (2014) Evaluation of aortic calcification with lanthanum carbonate vs. calcium-based phosphate binders in maintenance hemodialysis patients with type 2 diabetes mellitus: an open-label randomized controlled trial. Ther Apher Dial 18(4):353\u2013360","journal-title":"Ther Apher Dial"},{"issue":"5","key":"347_CR31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1074248413486355","volume":"18","author":"T Ohtake","year":"2013","unstructured":"Ohtake T, Kobayashi S, Oka M et al (2013) Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study. J Cardiovasc Pharmacol Ther 18(5):439\u2013446","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"9900","key":"347_CR32","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","volume":"382","author":"SA Jamal","year":"2013","unstructured":"Jamal SA, Vandermeer B, Raggi P et al (2013) Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382(9900):1268\u20131277","journal-title":"Lancet"},{"issue":"3","key":"347_CR33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2215\/CJN.05170513","volume":"9","author":"K Yokoyama","year":"2014","unstructured":"Yokoyama K, Hirakata H, Akiba T et al (2014) Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. Clin J Am Soc Nephrol 9(3):543\u2013552","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"347_CR34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/nep.12319","volume":"19","author":"HH Lin","year":"2014","unstructured":"Lin HH, Liou HH, Wu MS, Lin CY, Huang CC (2014) Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients. Nephrology (Carlton). 19(11):672\u2013678","journal-title":"Nephrology (Carlton)."},{"key":"347_CR35","first-page":"515606","volume":"2015","author":"O Phan","year":"2015","unstructured":"Phan O, Maillard M, Malluche HH, Stehle JC, Funk F, Burnier M (2015) Effects of sucroferric oxyhydroxide compared to lanthanum carbonate and sevelamer carbonate on phosphate homeostasis and vascular calcifications in a rat model of chronic kidney failure. Biomed Res Int 2015:515606","journal-title":"Biomed Res Int"},{"issue":"5","key":"347_CR36","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","volume":"307","author":"N Silswal","year":"2014","unstructured":"Silswal N, Touchberry CD, Daniel DR et al (2014) FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. Am J Physiol Endocrinol Metab 307(5):E426\u2013436","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"347_CR37","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W et al (2011) Chronic renal insufficiency cohort (CRIC) study group. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305:2432\u20132439","journal-title":"JAMA"},{"key":"347_CR38","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584\u2013592","journal-title":"N Engl J Med"},{"key":"347_CR39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","volume":"24","author":"G Jean","year":"2009","unstructured":"Jean G, Bresson E, Terrat JC et al (2009) Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transpl 24:948\u2013955","journal-title":"Nephrol Dial Transpl"},{"key":"347_CR40","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/ndt\/gfq089","volume":"25","author":"MM Nasrallah","year":"2010","unstructured":"Nasrallah MM, El-Shehaby AR, Salem MM et al (2010) Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transpl 25:2679\u20132685","journal-title":"Nephrol Dial Transpl"},{"key":"347_CR41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","volume":"83","author":"JJ Scialla","year":"2013","unstructured":"Scialla JJ, Lau WL, Reilly MP et al (2013) Chronic renal insufficiency cohort study investigators. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 83:1159\u20131168","journal-title":"Kidney Int"},{"key":"347_CR42","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","volume":"85","author":"R Jimbo","year":"2014","unstructured":"Jimbo R, Kawakami-Mori F, Mu S et al (2014) Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int 85:1103\u20131111","journal-title":"Kidney Int"},{"issue":"1","key":"347_CR43","doi-asserted-by":"crossref","first-page":"c15","DOI":"10.1159\/000149239","volume":"110","author":"AJ Hutchison","year":"2008","unstructured":"Hutchison AJ, Barnett ME, Krause R, Kwan JT, Siami GA (2008) SPD405-309 lanthanum study group. Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6\u00a0years of treatment. Nephron Clin Pract 110(1):c15\u201323","journal-title":"Nephron Clin Pract"},{"issue":"12","key":"347_CR44","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1681\/ASN.2006020156","volume":"17","author":"M Yoshino","year":"2006","unstructured":"Yoshino M, Kuhlmann MK, Kotanko P et al (2006) International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 17(12):3510\u20133519","journal-title":"J Am Soc Nephrol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-017-0347-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T11:23:49Z","timestamp":1519039429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-017-0347-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,20]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1007\/s00223-017-0347-3","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,20]]}}}